|
|
|
|
|
|
|
|
|
|
Cancer Research and Treatment
Materials and Methods Clinical data were reviewed in 28 patients who received FOLFOX-4 as more than the second-line chemotherapy
Saturday, April 27, 2013
Korean Cancer Association:: Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cance
Cancer Research and Treatment
Materials and Methods Clinical data were reviewed in 28 patients who received FOLFOX-4 as more than the second-line chemotherapy
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.